EIBIR GEMEINNUTZIGE GMBH ZUR FORDERUNG DER ERFORSCHUNG DER BIOMEDIZINISCHEN BILDGEBUNG

Their core work

EIBIR (European Institute for Biomedical Imaging Research) is a Vienna-based non-profit that acts as the coordination hub for Europe's biomedical imaging research community. They organize multi-national research projects spanning cancer diagnostics, radiation protection, and medical imaging innovation — bridging the gap between clinical radiology, technical imaging R&D, and EU policy. EIBIR manages large consortia, sets strategic research agendas for medical radiation applications, and increasingly facilitates the integration of AI tools into cancer imaging workflows. Their role is fundamentally that of a network orchestrator: they don't manufacture devices or treat patients, but they connect the institutions that do.

What they specialise in

How they've shifted over time

In the early period (2015–2018), EIBIR focused heavily on advanced imaging hardware and techniques — hybrid PET/MRI for breast cancer, ultrasound-optical diagnostics, and GlucoCEST metabolic imaging. The technical emphasis was on combining multiple imaging modalities to improve cancer detection accuracy. From 2019 onward, the focus shifted markedly toward radiation safety policy (MEDIRAD, SINFONIA), strategic roadmapping for the European medical radiation community (EURAMED), and AI-powered cancer image platforms (CHAIMELEON, EuCanImage). This evolution reflects a move from technical imaging R&D toward governance, data infrastructure, and translating imaging research into clinical AI tools.

EIBIR is positioning itself at the intersection of medical AI regulation and large-scale cancer imaging data, making them a strong partner for projects combining radiology, AI, and clinical data governance.

How they like to work

EIBIR operates as both a consortium leader (5 coordinated projects) and an active partner (7 participations), showing comfort in both roles. With 150 unique partners across 23 countries, they function as a major European hub — more a network connector than a specialist contributor. Their coordination projects tend to be strategic or policy-oriented (CSAs like EURAMED, EURO-CAS), while they join technical RIAs as a participant, suggesting they bring consortium management and community reach rather than lab capacity.

EIBIR has collaborated with 150 unique partners across 23 countries, making them one of the most connected organizations in European biomedical imaging. Their network spans university hospitals, radiology departments, imaging device manufacturers, and AI research groups across virtually all EU member states.

What sets them apart

EIBIR is not a university lab or a device company — it is the institutional backbone of Europe's biomedical imaging research community. Their ability to assemble and manage large, multi-country consortia (150 partners, 23 countries) makes them an unmatched coordination partner for any imaging-related project. For consortium builders, EIBIR brings instant access to Europe's radiology and imaging network, plus proven experience managing both technical research and strategic policy projects.

Highlights from their portfolio

• SINFONIA
  Largest single project budget (EUR 576,875) and coordinated by EIBIR — focused on radiation risk in cancer patient management, reflecting their growing leadership in medical radiation safety.
• CHAIMELEON
  Represents EIBIR's pivot toward AI — building a European cancer imaging repository with regulatory compliance frameworks, connecting their imaging expertise with machine learning applications.
• EURAMED rocc-n-roll
  A Coordination & Support Action where EIBIR defined the strategic research agenda for all European medical radiation research — a community leadership role few organizations can claim.